rAAV production revisited - from plasmid design to nanopore sequencing and proteomics
Radukic M, Le DT, Golm SK, Rothschild C, Hoffrogge R, Müller K (2022)
In: ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstractss. Human Gene Therapy, 33(23-24). Mary Ann Liebert: A101.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Einrichtung
Erscheinungsjahr
2022
Titel des Konferenzbandes
ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstractss
Serien- oder Zeitschriftentitel
Human Gene Therapy
Band
33
Ausgabe
23-24
Seite(n)
A101
Konferenz
29th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy (ESCGT)
Konferenzort
Edinburgh, UK
Konferenzdatum
2022-10-11 – 2022-10-14
ISSN
1043-0342
eISSN
1557-7422
Page URI
https://pub.uni-bielefeld.de/record/2968503
Zitieren
Radukic M, Le DT, Golm SK, Rothschild C, Hoffrogge R, Müller K. rAAV production revisited - from plasmid design to nanopore sequencing and proteomics. In: ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstractss. Human Gene Therapy. Vol 33. Mary Ann Liebert; 2022: A101.
Radukic, M., Le, D. T., Golm, S. K., Rothschild, C., Hoffrogge, R., & Müller, K. (2022). rAAV production revisited - from plasmid design to nanopore sequencing and proteomics. ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstractss, Human Gene Therapy, 33, A101. Mary Ann Liebert. https://doi.org/10.1089/hum.2022.29225.abstracts
Radukic, Marco, Le, D. T., Golm, Susanne Katharina, Rothschild, Claire, Hoffrogge, Raimund, and Müller, Kristian. 2022. “rAAV production revisited - from plasmid design to nanopore sequencing and proteomics”. In ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstractss, 33:A101. Human Gene Therapy. Mary Ann Liebert.
Radukic, M., Le, D. T., Golm, S. K., Rothschild, C., Hoffrogge, R., and Müller, K. (2022). “rAAV production revisited - from plasmid design to nanopore sequencing and proteomics” in ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstractss Human Gene Therapy, vol. 33, (Mary Ann Liebert), A101.
Radukic, M., et al., 2022. rAAV production revisited - from plasmid design to nanopore sequencing and proteomics. In ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstractss. Human Gene Therapy. no.33 Mary Ann Liebert, pp. A101.
M. Radukic, et al., “rAAV production revisited - from plasmid design to nanopore sequencing and proteomics”, ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstractss, Human Gene Therapy, vol. 33, Mary Ann Liebert, 2022, pp.A101.
Radukic, M., Le, D.T., Golm, S.K., Rothschild, C., Hoffrogge, R., Müller, K.: rAAV production revisited - from plasmid design to nanopore sequencing and proteomics. ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstractss. Human Gene Therapy. 33, p. A101. Mary Ann Liebert (2022).
Radukic, Marco, Le, D. T., Golm, Susanne Katharina, Rothschild, Claire, Hoffrogge, Raimund, and Müller, Kristian. “rAAV production revisited - from plasmid design to nanopore sequencing and proteomics”. ESGCT 29th Annual Congress. In collaboration with BSGCT Edinburgh, UK October 11–14, 2022, Abstractss. Mary Ann Liebert, 2022.Vol. 33. Human Gene Therapy. A101.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar